Hims Hers Health (HIMS) has had the highest return this year by a large-cap US stock, returning 100.2%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Hims Hers Health (HIMS) | 2025 | 100.16% |
Super Micro Computer (SMCI) | 2025 | 81.05% |
Alibaba (BABA) | 2025 | 70.34% |
Xpeng (XPEV) | 2025 | 59.03% |
Futu (FUTU) | 2025 | 54.3% |
Intracellular Th (ITCI) | 2025 | 52.8% |
Dutch Bros (BROS) | 2025 | 44.13% |
CVS Health (CVS) | 2025 | 42.51% |
Nebius (NBIS) | 2025 | 41.61% |
BeiGene (ONC) | 2025 | 39.93% |
PDD (PDD) | 2025 | 37.4% |
Gold Fields Ltd ADR (GFI) | 2025 | 35.61% |
Bancolombia SA ADR (CIB) | 2025 | 35.15% |
Banco Santander SA ADR (SAN) | 2025 | 34.9% |
Spotify Technology (SPOT) | 2025 | 34.8% |
Banco Bilbao Viscaya Argentaria SA ADR (BBVA) | 2025 | 34.29% |
Doximity (DOCS) | 2025 | 34.27% |
Robinhood Markets (HOOD) | 2025 | 33.89% |
AngloGold Ashanti (AU) | 2025 | 33.39% |
Palantir Technologies Inc Class A Common Stock (PLTR) | 2025 | 33.01% |
Cloudflare (NET) | 2025 | 32.72% |
MercadoLibre (MELI) | 2025 | 31.75% |
Royalty Pharma (RPRX) | 2025 | 30.8% |
Ecopetrol SA ADR (EC) | 2025 | 30.38% |
Tamboran Resources (TBN) | 2025 | 29.76% |
Large-cap stocks are treated as having a market cap of $10B+.
